GGrantIndex
Sort

51,593 grants matching hepatitis

Research to Improve and Standardize Marmoset Nutrition and Dietary Husbandry

$602,882
Suzette D Tardif · Texas Biomedical Research Institute · R24 · FY2018 · OD

Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)

$602,699
Manal M Hassan · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring

$602,601
Teri L Hernandez · University Of Colorado Denver · R01 · FY2018 · DK

Role of alcohol adapted Kupffer cells in the progression and resolution of ALD

$602,586
Steven A Weinman · University Of Kansas Medical Center · R01 · FY2025 · AA

Role of alcohol adapted Kupffer cells in the progression and resolution of ALD

$602,586
Steven A Weinman · University Of Kansas Medical Center · R01 · FY2024 · AA

Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance

$602,537
Gretchen Lano Birbeck · University Of Rochester · R01 · FY2021 · NS

Interventions to Increase HBV Vaccination in STD Clinics

$602,474
Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2005 · AI

Metabolic architecture of insulin action in Southwest American Indians

$602,440
Ravi Shah · Massachusetts General Hospital · U01 · FY2020 · DK

Varenicline for the treatment of cocaine dependence: Phase II

$602,429
Jennifer Grace Plebani · University Of Pennsylvania · U01 · FY2012 · DA

Structure and function of the HCV replication complex

$602,418
Anna Marie Pyle · Yale University · R01 · FY2010 · AI

HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS

$602,417
National Development &Res Institutes · R01 · FY2002 · DA

Interventions to Increase HBV Vaccination in STD Clinics

$602,254
Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2002 · AI

LIVOPT -- LIVer cirrhosis - Optimizing Prediction of Patient OuTcomes

$602,254
Daniela P Ladner · Northwestern University At Chicago · R01 · FY2023 · AG

LIVOPT -- LIVer cirrhosis - Optimizing Prediction of Patient OuTcomes

$602,254
Daniela P Ladner · Northwestern University At Chicago · R01 · FY2024 · AG

On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia

$602,209
Jason Joseph Winnick · University Of Cincinnati · R01 · FY2024 · DK

Active HCV diagnosis to support prevention of HCC in LMICs

$602,207
Sally M McFall · Northwestern University · U01 · FY2025 · CA

IRAKM and MINCLE in ALD

$602,163
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AA

IRAKM and MINCLE in ALD

$602,163
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AA

IRAKM and MINCLE in ALD

$602,163
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · AA

Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human Primates

$602,100
Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK

HIV Risks and Transitions to Injection among Non-IDUs

$601,994
Universidad Central Del Caribe · R01 · FY2005 · DA

Development of a Microfluidic Point-of-Care HCV Viral Load Assay

$601,984
Marta Fernandez-Suarez · Daktari Diagnostics, Inc. · R44 · FY2015 · AI

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

$601,971
David Fiellin · Yale University · U01 · FY2012 · AA

Small Molecule Inhibitors Targeting Adenovirus

$601,915
Charles E McKenna · University Of Southern California · R01 · FY2020 · AI

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

$601,908
Charles J Neighbors · New York University School Of Medicine · R33 · FY2022 · DA